Advertisement

Topics

Study Shows Inhibitor Efficiently Targets Cancer Associated Fibroblasts

05:50 EDT 7 Aug 2017 | PharmPro

Genkyotex's GKT831 shown to delay tumor growth in multiple preclinical models by targeting cancer associated fibroblasts. Based on the results, researchers believe that GKT831 has the potential to be an effective adjunctive cancer treatment.
Contributed Author: 
Genkyotex

Original Article: Study Shows Inhibitor Efficiently Targets Cancer Associated Fibroblasts

NEXT ARTICLE

More From BioPortfolio on "Study Shows Inhibitor Efficiently Targets Cancer Associated Fibroblasts"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...